|
1
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen K, Ma J, Jia X, Ai W, Ma Z and Pan Q:
Advancing the understanding of NAFLD to hepatocellular carcinoma
development: From experimental models to humans. Biochim Biophys
Acta Rev Cancer 1871. 117–125. 2019. View Article : Google Scholar
|
|
5
|
Tessitore A, Cicciarelli G, Del Vecchio F,
Gaggiano A, Verzella D, Fischietti M, Mastroiaco V, Vetuschi A,
Sferra R, Barnabei R, et al: MicroRNA expression analysis in high
fat diet-induced NAFLD-NASH-HCC progression: Study on C57BL/6J
mice. BMC Cancer. 16:32016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian Y, Lyu H, He Y, Xia Y, Li J and Shen
F: Comparison of hepatectomy for patients with metabolic
syndrome-related HCC and HBV-related HCC. J Gastrointest Surg.
22:615–623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dhar D, Seki E and Karin M: NCOA5, IL-6,
type 2 diabetes, and HCC: The deadly quartet. Cell Metab. 19:6–7.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pazgan-Simon M, Simon KA, Jarowicz E,
Rotter K, Szymanek-Pasternak A and Zuwała-Jagiełło J: Hepatitis B
virus treatment in hepatocellular carcinoma patients prolongs
survival and reduces the risk of cancer recurrence. Clin Exp
Hepatol. 4:210–216. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li WQ, Park Y, McGlynn KA, Hollenbeck AR,
Taylor PR, Goldstein AM and Freedman ND: Index-based dietary
patterns and risk of incident hepatocellular carcinoma and
mortality from chronic liver disease in a prospective study.
Hepatology. 60:588–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singh S, Singh PP, Roberts LR and Sanchez
W: Chemopreventive strategies in hepatocellular carcinoma. Nat Rev
Gastroenterol Hepatol. 11:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Y, Ying HY, Qu Y, Cai XB, Xu MY and
Lu LG: Novel matrine derivative MD-1 attenuates hepatic fibrosis by
inhibiting EGFR activation of hepatic stellate cells. Protein Cell.
7:662–672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH,
Xu J, Hu HG, Qiu L, Li JZ, et al: A novel matrine derivate inhibits
differentiated human hepatoma cells and hepatic cancer stem-like
cells by suppressing PI3K/AKT signaling pathways. Acta Pharmacol
Sin. 38:120–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao L, Wang KX, Zhou YZ, Fang JS, Qin XM
and Du GH: Uncovering the anticancer mechanism of Compound Kushen
Injection against HCC by integrating quantitative analysis, network
analysis and experimental validation. Sci Rep. 8:6242018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Zhang S, Liu J, Fang B, Yao J and
Cheng B: Matrine inhibits the invasive and migratory properties of
human hepatocellular carcinoma by regulating epithelial-mesenchymal
transition. Mol Med Rep. 18:911–919. 2018.PubMed/NCBI
|
|
15
|
Zhou H, Xu M, Gao Y, Deng Z, Cao H, Zhang
W, Wang Q, Zhang B, Song G, Zhan Y and Hu T: Matrine induces
caspase-independent program cell death in hepatocellular carcinoma
through bid-mediated nuclear translocation of apoptosis inducing
factor. Mol Cancer. 13:592014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X and Yu H: Matrine inhibits
diethylnitrosamine-induced HCC proliferation in rats through
inducing apoptosis via p53, Bax-dependent caspase-3 activation
pathway and down-regulating MLCK overexpression. Iran J Pharm Res.
15:491–499. 2016.PubMed/NCBI
|
|
17
|
Wang Y, Yao R, Gao S, Wen W, Du Y, Szabo
E, Hu M, Lubet RA and You M: Chemopreventive effect of a mixture of
Chinese Herbs (antitumor B) on chemically induced oral
carcinogenesis. Mol Carcinog. 52:49–56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Zhang Z, Garbow JR, Rowland DJ,
Lubet RA, Sit D, Law F and You M: Chemoprevention of lung squamous
cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev
Res (Phila). 2:634–640. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bigas A and Espinosa L: The multiple
usages of Notch signaling in development, cell differentiation and
cancer. Curr Opin Cell Biol. 55:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ni MM, Wang YR, Wu WW, Xia CC, Zhang YH,
Xu J, Xu T and Li J: Novel Insights on Notch signaling pathways in
liver fibrosis. Eur J Pharmacol. 826:66–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi D and Zhang J, Qiu L, Li J, Hu Z and
Zhang J: Matrine inhibits infiltration of the inflammatory Gr1(hi)
monocyte subset in injured mouse liver through inhibition of
monocyte chemoattractant Protein-1. Evid Based Complement Alternat
Med 2013. 5806732013.
|
|
22
|
Yang Z, Wang L and Wang X: Matrine induces
the hepatic differentiation of WB-F344 rat hepatic progenitor cells
and inhibits Jagged 1/HES1 signaling. Mol Med Rep. 14:3841–3847.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Anilkumar TV, Golding M, Edwards RJ,
Lalani EN, Sarraf CE and Alison MR: The resistant hepatocyte model
of carcinogenesis in the rat: The apparent independent development
of oval cell proliferation and early nodules. Carcinogenesis.
16:845–853. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams JM, Oh SH, Jorgensen M, Steiger
N, Darwiche H, Shupe T and Petersen BE: The role of the wnt family
of secreted proteins in rat oval ‘Stem’ cell-based liver
regeneration: Wnt1 drives differentiation. Am J Pathol.
176:2732–2742. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yovchev MI, Grozdanov PN, Joseph B, Gupta
S and Dabeva MD: Novel hepatic progenitor cell surface markers in
the adult rat liver. Hepatology. 45:139–149. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang K, Zhang J, Yin C, Zhou X and Zhou
S: Protective effects and mechanism of TPX2 on neurocyte apoptosis
of rats in Alzheimer's disease model. Exp Ther Med. 13:576–580.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu JH, Feng D, Zhang YF, Shang Y, Wu Y,
Li XF and Pei L: Chloral hydrate preconditioning protects against
ischemic stroke via upregulating Annexin A1. CNS Neurosci Ther.
21:718–726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng X, Zhang L, Sun L, Zhang D, Zhao H,
Jia J and Wang W: Recovery from rat sciatic nerve injury in
vivo through the use of differentiated MDSCs in vitro.
Exp Ther Med. 5:193–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Perks WV, Singh RK, Jones GW, Twohig JP,
Williams AS, Humphreys IR, Taylor PR, Jones SA and Wang ECY: Death
receptor 3 promotes chemokine-directed leukocyte recruitment in
acute resolving inflammation and is essential for pathological
development of mesothelial fibrosis in chronic disease. Am J
Pathol. 186:2813–2823. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soslow RA, Dannenberg AJ, Rush D, Woerner
BM, Khan KN, Masferrer J and Koki AT: COX-2 is expressed in human
pulmonary, colonic, and mammary tumors. Cancer. 89:2637–2645. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li CH, Wang YJ, Dong W, Xiang S, Liang HF,
Wang HY, Dong HH, Chen L and Chen XP: Hepatic oval cell lines
generate hepatocellular carcinoma following transfection with HBx
gene and treatment with aflatoxin B1 in vivo. Cancer Lett.
311:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yovchev MI, Xue Y, Shafritz DA, Locker J
and Oertel M: Repopulation of the fibrotic/cirrhotic rat liver by
transplanted hepatic stem/progenitor cells and mature hepatocytes.
Hepatology. 59:284–295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Farber E: Cellular biochemistry of the
stepwise development of cancer with chemicals: G. H. A. Clowes
memorial lecture. Cancer Res. 44:5463–5474. 1984.PubMed/NCBI
|
|
34
|
Zhang J, Gao Y, Han H, Zou C, Feng Y and
Zhang H: Matrine suppresses lung metastasis of human hepatocellular
carcinoma by directly targeting matrix metalloproteinase-9. Biochem
Biophys Res Commun. 515:57–63. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chagas CE, Bassoli BK, de Souza CA,
Deminice R, Jordão Júnior AA, Paiva SA, Dagli ML, Ong TP and Moreno
FS: Folic acid supplementation during early hepatocarcinogenesis:
Cellular and molecular effects. Int J Cancer. 129:2073–2082. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beltran-Ramírez O, Pérez RM,
Sierra-Santoyo A and Villa-Trevino S: Cancer prevention mediated by
caffeic acid phenethyl ester involves cyp2b1/2 modulation in
hepatocarcinogenesis. Toxicol Pathol. 40:466–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang CH, Chang HY, Chen YC, Lu CC, Huang
SS, Huang GJ and Lai HC: Ethanol extract of Phellinus
merrillii protects against diethylnitrosamine- and
2-acetylaminofluorene-induced hepatocarcinogenesis in rats. Chin J
Integr Med. 23:117–124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu XB, Lo CM, Cheng Q, NG KT, Shao Y, Li
CX, Chung SK, Ng IOL, Yu J and Man K: Oval cells contribute to
fibrogenesis of marginal liver grafts under stepwise regulation of
aldose reductase and notch signaling. Theranostics. 7:4879–4893.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang ZY, Wang L, Hou YX and Wang XB:
Effects of matrine on oval cellmediated liver regeneration and
expression of RBP-Jκ and HES1. Mol Med Rep. 7:1533–1538. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Z, Wang Y, Zhu H, Qiu C, Guan G, Wang
J and Guo Y: Matrine blocks GEs-induced HCSMCs phenotypic
conversion via suppressing Dll4-Notch pathway. Eur J Pharmacol.
835:126–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dezsö K, Papp V, Bugyik E, Hegyesi H,
Sáfrány G, Bödör C, Nagy P and Paku S: Structural analysis of
oval-cell-mediated liver regeneration in rats. Hepatology.
56:1457–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gu YM, Lu JY, Sun W, Jin RM, Ohira T,
Zhang Z and Tian XS: Oxymatrine and its metabolite matrine
contribute to the hepatotoxicity induced by radix Sophorae
tonkinensis in mice. Exp Ther Med. 17:2519–2528. 2019.PubMed/NCBI
|
|
43
|
Jia Y, Long S, Jiang N, Shan Z, Lu Y, Han
F, Yu J and Feng L: Oxymatrine ameliorates agomelatine-induced
hepatocyte injury through promoting proteasome-mediated CHOP
degradation. Biomed Pharmacother. 114:1087842019. View Article : Google Scholar : PubMed/NCBI
|
